Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Prepaid Assets: 2012-2025

Historic Prepaid Assets for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Sep 2025 value amounting to $8.6 million.

  • Enanta Pharmaceuticals' Prepaid Assets fell 30.80% to $8.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.6 million, marking a year-over-year decrease of 30.80%. This contributed to the annual value of $8.6 million for FY2025, which is 30.80% down from last year.
  • According to the latest figures from FY2025, Enanta Pharmaceuticals' Prepaid Assets is $8.6 million, which was down 30.80% from $12.4 million recorded in FY2024.
  • Enanta Pharmaceuticals' Prepaid Assets' 5-year high stood at $14.2 million during FY2021, with a 5-year trough of $8.6 million in FY2025.
  • Its 3-year average for Prepaid Assets is $11.4 million, with a median of $12.4 million in 2024.
  • In the last 5 years, Enanta Pharmaceuticals' Prepaid Assets grew by 3.90% in 2021 and then crashed by 30.80% in 2025.
  • Over the past 5 years, Enanta Pharmaceuticals' Prepaid Assets (Yearly) stood at $14.2 million in 2021, then decreased by 5.24% to $13.4 million in 2022, then declined by 1.35% to $13.3 million in 2023, then declined by 6.41% to $12.4 million in 2024, then plummeted by 30.80% to $8.6 million in 2025.